SecBot SecBot
424B4 ·Filed May 19, 2026

AMAN

Amanat Acquisition Corp.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001213900-26-059197
Prospectus supplement
Actionable Insight • Neutral

Monitor for any business combination announcements within the 24-month window. The experienced management team may accelerate deal sourcing. Public shareholders should be aware of potential dilution from founder shares and the risk of no deal being completed.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
AMAN ▲ +3.86% at T+60d
NEUTRAL call +3.86% · α vs SPY -1.14% · entry $10.10 → $10.49
Entry = T+0 close
May 20, 2026
via day close
T+1d
+0.30%
call +0.30% · α +0.10%
$10.13
settled 5mo ago
T+5d
+0.40%
call +0.40% · α -1.41%
$10.14
settled 5mo ago
T+20d
-0.20%
call -0.20% · α -0.94%
$10.08
settled 4mo ago
T+60d
+3.86%
call +3.86% · α -1.14%
$10.49
settled 2mo ago

Executive Summary

Amanat Acquisition Corp. priced its SPAC IPO of 7.5 million Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds, plus a $3 million private placement from the sponsor. The blank-check company targets a healthcare/life sciences business within 24 months. Public investors face immediate dilution from founder shares purchased at ~$0.012 per share.

Key Financial Metrics

Offering Size
$75.0M
Dilution
19.4%
Underwriters
Leerink Partners

Key Facts

  • 7,500,000 Class A ordinary shares offered at $10.00 per share, raising $75 million
  • Sponsor purchased 300,000 private placement shares at $10.00 each, totaling $3 million
  • No warrants issued, unlike many SPAC IPOs
  • 24-month window to complete a business combination, focusing on healthcare/life sciences
  • Founder shares 2,156,250 at ~$0.012 per share, representing ~20% of post-offering shares
  • Underwriter: Leerink Partners; trust account holds $75 million including $2.25 million deferred underwriting fees

Financial Impact

$75 million gross IPO proceeds plus $3 million private placement, with $75 million deposited in trust

dilutioncash position

Risk Factors

  • Significant dilution from founder shares acquired at nominal price
  • No target identified yet; risk of failing to complete a business combination within 24 months
  • Potential for high redemptions at deal time, reducing trust account cash available

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001213900-26-059197
Document: 0001213900-26-059197-index-headers.html0001213900-26-059197
Document: 0001213900-26-059197-index.html0001213900-26-059197
Document: 0001213900-26-059197.txt0001213900-26-059197
10 reports for AMAN
Performance horizon
Filters
Rows
Reports for AMAN — sortable, filterable
TypeNow
Oct 26, 2026
today
425
NEUTRAL ★ 5/10
—awaiting T+20——
Oct 26, 2026
today
8-K
NEUTRAL ★ 6/10
$10.39awaiting T+20—$10.14 (−2.41%)
May 27, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$10.14 $10.08▼ −0.59%▲ +2.55%$10.14 (+0.00%)
May 21, 2026
22w ago
8-K
NEUTRAL ★ 5/10
$10.13 $10.08▼ −0.54%▼ −0.88%$10.14 (+0.10%)
May 19, 2026
22w ago
424B4
NEUTRAL ★ 4/10
$10.10 $10.08▼ −0.20%▼ −0.94%$10.14 (+0.40%)
May 19, 2026
22w ago
3
NEUTRAL ★ 1/10
$10.10 $10.08▼ −0.20%▼ −0.94%$10.14 (+0.40%)
May 19, 2026
22w ago
3
NEUTRAL ★ 2/10
$10.10 $10.08▼ −0.20%▼ −0.94%$10.14 (+0.40%)
May 19, 2026
22w ago
3
NEUTRAL ★ 2/10
$10.10 $10.08▼ −0.20%▼ −0.94%$10.14 (+0.40%)
May 19, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$10.01 $10.08▲ +0.70%▼ −0.29%$10.14 (+1.30%)
May 14, 2026
23w ago
S-1/A
NEUTRAL ★ 4/10
—awaiting T+20——
Showing 10 of 10

US Market Status

Market Open — Closes in 4h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 20, 2026